Skip to content

Evaluation of the efficacy after 1 year of AIT treatment for chinese dust mite allergic rhinitis patients with or without asthma in different sensitization modes

A multicenter, prospective, observational study: Evaluation of the efficacy after 1 year of AIT treatment for chinese dust mite allergic rhinitis patients with or without asthma in different sensitization modes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078642
Enrollment
Unknown
Registered
2023-12-14
Start date
2023-12-18
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) 5 years = age =65 years 2) allergic rhinitis with or without allergic asthma caused by dust mite allergens 3) If accompanied by bronchial asthma, ensure that their asthma symptoms are well controlled 4) Received standard anti-allergy medication at least 1 year before enrollment

Exclusion criteria

Exclusion criteria: 1) In the judgment of the investigator, the subject and/or parent/legal guardian are unable to understand and comply with the requirements of the study 2) Contraindications of AIT 3) Poor compliance

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
serum IgE;AEs information;

Countries

China

Contacts

Public ContactZhu Rongfei

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

zrf13092@163.com+86 189 8629 2602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026